Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.
about
Targeting the insulin-like growth factor pathway in hepatocellular carcinomaLow expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinomaThe diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis.Insulin-Like Growth Factor (IGF) System in Liver Diseases.extracts alleviate muscle damage and promote anaerobic performance of trained male boxers and its mechanisms: Roles of androgen, IGF-1, and IGF binding protein-3
P2860
Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Serum IGFBP-3 is a more effect ...... ts with chronic HCV infection.
@ast
Serum IGFBP-3 is a more effect ...... ts with chronic HCV infection.
@en
type
label
Serum IGFBP-3 is a more effect ...... ts with chronic HCV infection.
@ast
Serum IGFBP-3 is a more effect ...... ts with chronic HCV infection.
@en
prefLabel
Serum IGFBP-3 is a more effect ...... ts with chronic HCV infection.
@ast
Serum IGFBP-3 is a more effect ...... ts with chronic HCV infection.
@en
P2093
P2860
P356
P1433
P1476
Serum IGFBP-3 is a more effect ...... nts with chronic HCV infection
@en
P2093
Ahmed Gowily
Amal Refaat Mansour
Asmaa Hela
Ayman Elshayeb
Nihal Elhabachi
P2860
P304
P356
10.3892/OL.2011.546
P50
P577
2011-12-30T00:00:00Z